Protocatechuic acid influences immune-metabolic changes in the adipose tissue of pregnant women with gestational diabetes mellitus. Issue 16 (2nd July 2021)

• Record Type: Journal Article
• Authors: Scazzocchio, Beatrice; Filardi, Tiziana; Varì, Rosaria; Brunelli, Roberto; Galoppi, Paola; Morano, Susanna; Masella, Roberta; Santangelo, Carmela
• Is Part Of: Food & function. Volume 12:Issue 16(2021)
• Page Start: 7490
• Page End: 7500
• Publication Date: 2021-07-02
• Subjects: Food -- Analysis -- Periodicals; Food -- Composition -- Periodicals; Nutrition -- Periodicals; 664.07
• DOI: 10.1039/d1fo00267h
• Languages: English
• ISSNs: 2042-6496

Abstract

Abstract : Protocatechuic acid increased glucose uptake by p38MAPKinase activation, and rebalanced the inflammatory status by stimulating adiponectin release and reducing VPAC2 in adipose tissue explants from women with GDM. Abstract : Gestational diabetes mellitus (GDM) is associated with immune metabolic changes that increase women's risk of developing metabolic disorders later in life. Nutritional intervention is a crucial component in reducing the burden of these pathological features. We examined whether protocatechuic acid (PCA), a major metabolite of anthocyanins abundant in plant food, is able to exert insulin-mimetic activity and modulate inflammation in the visceral adipose tissue (VAT) obtained at delivery, from pregnant women with GDM or normal glucose tolerance (NGT). PCA stimulated glucose uptake in the VAT from both GDM and NGT women. This capability was associated with increased phosphorylation of p38 mitogen-activated protein kinase (p38MAPK), as further demonstrated by the inhibitory effect of SB203580, a p38MAPK inhibitor, on PCA-induced glucose uptake. The GDM-VAT expressed lower adiponectin levels and PCA stimulated adiponectin release in the NGT-VAT and, albeit to a lower extent, in the GDM-VAT. Higher levels of IL6 and TNFα were secreted by the GDM-VAT compared with the NGT one, and PCA had no effects on them. PCA reduced the overexpression of vasoactive intestinal peptide receptor 2 (VPAC2) in the GDM-VAT. Further studies are needed to establish whether and how anthocyanins and food rich in these compounds may contribute to prevent or delay metabolic disorders in women with GDM.